As the sensitivity and variety of tests increase, the types and tolerable c
oncentrations of impurities that may inhibit clinical tests become an incre
asing concern. Because water constitutes a high percentage of the buffers a
nd reaction mixtures used in clinical assays, the use of high-purity water
is critical for reliable, consistent, and cost-effective laboratory analysi
s. A wide range of contaminants exists in potable water supplies and must b
e removed with a water system containing the proper combination of specific
purification technologies. Technologies such as activated carbon, reverse
osmosis, ion exchange, and distillation have particular purification capabi
lities and must be selected based on their ability to consistently produce
water with purity suitable for specific test methods. The National Committe
e for Clinical Laboratory Standards (NCCLS) provides guidelines for the pro
duction and use of purified water in the laboratory. The production of reag
ent water that meets the NCCLS guidelines requires proper measurement and m
onitoring of contaminant level in both incoming source water and product re
agent water The introduction of new diagnostic tests requires the removal a
nd monitoring of contaminants, such as nucleases and extraneous DNA, and cr
eates new criteria for water purity and water system design. Current water
purification technologies are reviewed, and a system designed to provide ty
pe I water is discussed.